Search Results

101 - 110 of 490 items :

  • "prostate cancer" x
Clear All
MicroRNAs and long non-coding RNAs: prospects in diagnostics and therapy of cancer

XB, Xue L, Yang J, Ma AH, Zhao J, Xu M, et al. An androgen-regulated miRNA suppresses Bak1 expression and induces androgen-independent growth of prostate cancer cells . Proc Natl Acad Sci USA 2007; 104: 19983-8. 43. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities . Nat Med 2008; 14: 1271-7. 44. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V, et al. Regulatory Role of mir-203 in Prostate Cancer

Open access
Immunohistochemical Localization of Elastic System Fibres in the Canine Prostate

. Histol. Cytol. , 56, 441—449. 11. Murakumo, M., Ushiki, T., Abe, K., Matsumura, K., Shinno, Y., Koyanagi, T., 1995: Three dimensional arrangement of collagen and elastin fibres in the human urinary bladder: a scanning electron microscopic study. J. Urol. , 154, 251—256. 12. Sugimoto, K., Matsumoto, S., Uemura, H., Ito, H., 2008: Distribution of elastic fibers on prostate. Hinyokika kiyo. Acta Urol. Japonica , 54, 321—324. 13. Tuxhorn, J. A., Ayala, G. E., Rowley, D. R., 2001: Reactive stroma in prostate cancer progression. J. Urol. , 166, 2472

Open access
Influence of Membership Functions on Classification of Multi-Dimensional Data

: Class Discovery and Class Prediction by Gene Expression Monitoring," in Science. , Vol. 286, 1999, pp. 531-537. D Singh. et all, "Gene Expression Correlates of Clinical Prostate Cancer Behavior," Cancer Cell , Vol. 1, No. 2, March 2002, pp. 203-209. Broad Institute, "Broad institute home page" 2010. [Online]. Available:

Open access
Technical report. Accuracy of intensity-modulated radiation therapy dose calculations: verification based on-board conebeam CT imaging

J, Sonke JJ, Betgen A, Zijp L, Jaffray DA, et al. Automatic prostate localization on cone-beam CT scans for high precision image-guided radiotherapy. Int J Radiat Oncol Biol Phys. 2005; 63: 975-84. 10. Mageras GS, Mechalakos. Planning in the IGRT context: closing the loop. Semin Radiat Oncol. 2007; 17:268-77. 11. Melancon AD, O’Daniel JC, Zhang L, Kudchadker RJ, Kuban DA, Lee AK, et al. Is a 3-mm intrafractional margin sufficient for daily image-guided intensitymodulated radiation therapy of prostate cancer? Radiather Oncol. 2007

Open access
Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma

’s of radiobiology revisited. Stem Cells 2010; 28: 639-48. 12. López-Ruiz P, Rodriguez-Ubreva J, Cariaga AE, Cortes MA, Colás B. SHP-1 in cell-cycle regulation. Anticancer Agents Med Chem 2011; 11: 89-98. 13. Rodriguez-Ubreva FJ, Cariaga-Martinez AE, Cortes MA, Romero-De Pablos M, Ropero S, López-Ruiz P, et al. Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery. Oncogene 2010; 29: 345-55. 14. Tassidis H

Open access
Influence of epilobium angustifolium extract on 5α-reductase type 2 and mapk3 kinase gene expression in rats prostates

(1):15-8. 4. Von Löw EC, Perabo FG, Siener R, Müller SC. Review. Facts and fiction of phytotherapy for prostate cancer: a critical assessment of preclinical and clinical data. In Vivo 2007; 21(2):189-204. 5. Dedhia RC, McVary KT. Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2008; 179(6):2119-25.PDR for Herbal Medicines. 4th ed. Thompson Healtcare Inc., USA 2007:903-4. 6. Van-Hellemont J. Compedium de Phytotherapie. Association Pharmaceutique, Brussels 1986. 7. Wichtl M. Herbal

Open access
The “question-mark” MR anatomy of the cervico-thoracic ganglia complex: can it help to avoid mistaking it for a malignant lesion on 68Ga-PSMA-11 PET/MR?

staging and follow-up of prostate cancer patients, turned out to gather also in sympathetic ganglia, including CTG/SG. 12 , 13 , 14 , 15 In such circumstances, the relatively small size of CTG/SG does not exclude them from suspicion of malignancy, when they show the radiotracer uptake on PET, because 68 Ga-PSMA ligand (PET/CT) has the functional potential do detect micrometastases even in non-enlarged, and therefore missed on only morphological CT assessment, lymph nodes. 16 , 17 Detection of uptake in CTG/SG on multimodal PET/CT imaging, causes the possibility

Open access
Metformin Impacts the Prognosis of Cancer Patients with Type 2 Diabetes

metformin associated with improved survival of diabetic prostate cancer patients. Ann Oncol 22: 2640-2645, 2011. 28. Spratt DE, Zhang C, Zumsteg ZS, Pei X, Zhang Z, Zelefsky MJ. Metformin and prostate cancer: Reduced development of castration-resistant disease and prostate cancer mortality. Eur Urol 63: 709-716, 2013. 29. Kaushik D, Karnes RJ, Eisenberg MS, Rangel LJ, Carlson RE, Bergstralh EJ. Effect of metformin on prostate cancer outcomes after radical prostatectomy. Urol Oncol 32: 43.e41-47, 2014. 30. Romero IL

Open access
Glycans as a Target in the Detection of Reproductive Tract Cancers

comparative study in human normal prostate, benign prostatic hyperplasia, and prostate cancer. Glycoconj J 1999; 16: 375-82. Chan FL, Choi HL, Ho SM. Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histochemistry and blotting. Prostate 2001; 46 (1): 21-32. Abel PD, Foster CS, Tebbutt S, Williams G. Differences in expression of oligosaccharide determinants by phenotypically distinct sublines of the Dunning

Open access
Effect of Changing Phantom Thickness on Helical Radiotherapy Plan: Dosimetric Analysis

, Lock M, Harari PM, et al. Clinical implementation of adaptive helical tomotherapy: a unique approach to image-guided intensity modulated radiotherapy. Tech Cancer Res Treat. 2006;5:465-479. [20] Piotrowski T, Kaczmarek K, Bajon T, et al. Evaluation of Image-Guidance Strategies for Prostate Cancer. Technol Cancer Res Treat. 2014;13(6):583-591. [21] Yan D. Adaptive radiotherapy: merging principle into clinical practice. Semin Radiat Oncol. 2010;20(2):79-83. [22] Thörnqvist S, Hysing LB, Tuomikoski L, et al. Adaptive radiotherapy strategies for pelvic

Open access